Tech Company Inital Public Offerings
Novan IPO
Novan, based in Morrisville, debuted as a public company on 9/21/2016.
Transaction Overview
Company Name
Announced On
9/21/2016
Transaction Type
IPO
Amount
$45,100,000
Proceeds Purpose
We currently expect to use the net proceeds from this offering, together with existing cash, as follows: (i) approximately $29.0 million to fund the development of SB204 through NDA submission; (ii) approximately $3.0 million to fund platform expansion with Phase 2 trials for SB206 and SB208; and (iii) the balance to fund internal research and development expenses associated with SB414 and future product candidates and for working capital and general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
4105 Hopson Rd.
Morrisville, NC 27560
USA
Morrisville, NC 27560
USA
Phone
Website
Email Address
Overview
Novan, Inc. (Nasdaq: NOVN) is a pharmaceutical company focused on redefining the standard of care in dermatology through the development and commercialization of innovative therapies using the Company's nitric oxide platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paula Stafford
Chief Technical Officer
Carri Geer
Vice President
Tomoko Maeda-Chubachi
VP - Bus. Development
Elizabeth Messersmith
VP - Finance
John Gay
Browse more venture capital transactions:
Prev: 9/21/2016: Allset venture capital transaction
Next: 9/21/2016: StarOfService venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs